Top 25 Companies in Digital PCR Market: Company Profile by Transpire Insight

By Transpire Insight

---

Description

According to a research report published by Transpire Insight, the digital PCR market size is projected to grow from USD 11.05 billion in 2026 to USD 18.24 billion by 2035, at a CAGR of 18.67% during the forecast period 2027-2035. Rising oncology research demands high-sensitivity mutation detection, while expanding cell and gene therapy manufacturing requires absolute quantification for vector copy numbers, overall target copy variations, and viral load monitoring.

Introduction 

The digital PCR (dPCR) market represents a major evolutionary leap in nucleic acid quantification, delivering absolute copy number measurements without requiring standard reference curves. By partitioning samples into micro-reactions via droplets or chips, dPCR provides unmatched precision, high target sensitivity, and tolerance to environmental PCR inhibitors. Its rapidly expanding adoption across precision oncology, rare mutation detection, infectious disease surveillance, and cell therapy quality control cements dPCR as an essential molecular tool.

Recent Development News 

January 2026: QIAGEN expanded its automated molecular workflow portfolio, setting 2026 priorities around its QIAcuity digital PCR platform to target higher laboratory sample throughput.

April 2026: QIAGEN reported double-digit CER sales growth for its QIAcuity digital PCR system, driven by strong demand for instruments and consumables.

Stay Ahead of Emerging Opportunities with Expert Market Insights by Transpire Insight

Transpire Insight provides comprehensive, data-driven market intelligence to support smarter business decisions. Our research is rooted in comprehensive analysis, authoritative predictions, and industry expertise, enabling organizations to make informed decisions in rapidly evolving markets. We provide in-depth analysis of market segmentation, competitive positioning, regional trends, and emerging investment opportunities in high-growth areas. We blend accuracy with actionable intelligence, helping companies uncover new growth avenues, strengthen strategic decision-making, and stay ahead in a dynamic market. 

Download the exclusive Digital PCR Market sample report today to explore expert insights, key trends, and emerging opportunities shaping the future of the industry.

Digital PCR Market Size & Statistics 

The Market Size for Digital PCR Was Estimated to be Worth USD 11.05 Billion in 2026.

The Market Size is Going to Expand at a CAGR of 18.67% between 2026 and 2035.

The Digital PCR Market Size is anticipated to reach USD 18.24 Billion by 2035.

North America is projected to drive the highest demand during the forecast period, accounting for 43.79% of the digital PCR market.

Asia-Pacific is projected to grow the fastest during the forecast period at a CAGR of 19.24% in the digital PCR market.

Regional Growth and Demand Analysis by Transpire Insight

North America remains the largest demand center for digital PCR, supported by a dense cluster of biotechnology companies, well-funded academic institutions, and an advanced molecular diagnostics ecosystem led by the United States. Instrument makers in the region keep refreshing their portfolios. Bio-Rad launched its QX Continuum and QX700 droplet digital PCR platforms, with higher multiplexing and throughput, after integrating Stilla Technologies. Researchers from the University of North Carolina and Indiana University also showed that Bio-Rad and QIAGEN platforms deliver equivalent quantitative performance for SARS-CoV-2 wastewater surveillance, which supports wider public health use. Europe is a mature and innovation-driven market. The In Vitro Diagnostic Regulation has pushed manufacturers toward clinically validated platforms, and the Horizon Europe work programme allocated more than €7.3 billion to research and innovation, including biotechnology and genomics. QIAGEN's partnership with ID Solutions has also widened the oncology assay menu on its QIAcuity platform across European research laboratories.

Asia Pacific is the growth engine of the market, driven by expanding biotechnology industries, improving healthcare infrastructure and government support for genomics and precision medicine. China is among the most dynamic markets, with domestic biotech companies, rising cancer diagnostics demand and growing biopharmaceutical production. Japan adds strength through precision oncology, regenerative medicine and cell and gene therapy research. Thermo Fisher Scientific recently opened a bioprocess design center in Hyderabad and expanded its centers in Singapore and South Korea, strengthening the molecular research base that supports dPCR adoption. Latin America is growing steadily as hospitals and diagnostic laboratories adopt molecular testing for oncology and infectious diseases. In the Middle East and Africa, Gulf Cooperation Council countries are investing in precision healthcare and laboratory infrastructure, which is expanding access to digital PCR platforms, although resource constraints still limit the pace.

Top 15 Trends in the Digital PCR Market

• Rising adoption of droplet digital PCR platforms.
• Growing use of liquid biopsy for cancer monitoring.
• Expanding minimal residual disease testing with dPCR.
• Increasing integration in cell and gene therapy manufacturing.
• Shift from qPCR toward absolute quantification workflows.
• Higher multiplexing capacity across new dPCR instruments.
• Rising demand for chip-based, compact dPCR systems.
• Automation and walk-away workflows in digital PCR labs.
• Growing wastewater surveillance using dPCR for pathogens.
• Expanding assay portfolios and recurring consumables revenue.
• Software, cloud analytics and LIMS integration gaining traction.
• Consolidation through acquisitions among dPCR technology providers.
• Growing clinical use in transplant monitoring diagnostics.
• Rising government funding for genomics and precision medicine.
• Expansion of local dPCR manufacturing across Asia Pacific.

Proceed to checkout to purchase the exclusive Digital PCR Market report and get instant access to detailed market insights, strategic analysis, and future growth opportunities.

1. Rising adoption of droplet digital PCR platforms

Droplet systems split samples into thousands of reactions, delivering high sensitivity and absolute quantification, making them the preferred platform for oncology, infectious disease, and research.

2. Growing use of liquid biopsy for cancer monitoring

Digital PCR detects rare circulating tumor DNA mutations, enabling clinicians to monitor treatment response and relapse noninvasively, which drives steady demand across precision oncology programs.

3. Increasing integration in cell and gene therapy manufacturing

Manufacturers use digital PCR for viral vector quantification, vector copy number, and residual host cell DNA, as growing gene therapy pipelines demand accurate quality control.

4. Higher multiplexing capacity across new dPCR instruments

Newer instruments detect several targets in a single well, reducing sample consumption and run time while allowing laboratories to analyze complex biomarker panels more efficiently.

5. Automation and walk-away workflows in digital PCR labs

Automated sample handling, integrated analysis, and walk-away operation reduce hands-on time and variability, helping clinical and biopharma laboratories scale digital PCR testing without additional staff.

6. Growing wastewater surveillance using dPCR for pathogens

Public health agencies use digital PCR to measure viral loads in wastewater accurately, supporting early outbreak detection and community surveillance of respiratory and infectious pathogens.

Top 25 Companies Leading the Digital PCR Market

• Bio-Rad Laboratories
• QIAGEN N.V.
• Thermo Fisher Scientific
• Roche Diagnostics
• Stilla Technologies
• Agilent Technologies
• Standard BioTools (formerly Fluidigm)
• JN Medsys
• Formulatrix
• Sysmex Corporation
• JN Biosciences
• RainDance Technologies (Acquired by Bio-Rad)
• Vazyme Biotech
• Tarson Products
• Takara Bio
• Promega Corporation
• Merck KGaA
• New England Biolabs (NEB)
• Bioron Diagnostics
• Apex BioResearch
• PreciseBio Technologies
• Gentaur Molecular Products
• GenoSensor
• AstraZeneca (Diagnostics Division)
• Illumina (Digital Assay Solutions)

Customize the exclusive Digital PCR Market report to receive insights tailored to your needs, including country-specific analysis and business-focused market intelligence.

1. Bio-Rad Laboratories
   pioneer establishing benchmark droplet digital PCR technologies across clinical diagnostic applications.Founded: 1952 | HQ: Hercules, California, USA.Why It Ranks: Market share dominance via extensive ddPCR platform adoption and assay portfolios.Regional Dominance: Strong leadership across North America, Western Europe, and Asia-Pacific markets.Product Line: QX600 Droplet Digital PCR System, QX200 AutoDG, Consumables, Custom Assays.
2. QIAGEN N.V.
   Major molecular testing developer leveraging nanoplate technology for rapid automated micro-partitioning.Founded: 1984 | HQ: Venlo, Netherlands.Why It Ranks: Rapid market expansion using integrated sample-to-result benchtop nanoplate dPCR automation.Regional Dominance: Powerful distribution across Europe, North America, and emerging Asia-Pacific markets.Product Line: QIAcuity Digital PCR Systems (One, Four, Eight), QIAcuity Nanoplates, Reagents.
3. Thermo Fisher Scientific
   life science leader advancing chip-based digital PCR technology for high-throughput quantification.Founded: 1956 | HQ: Waltham, Massachusetts, USA.Why It Ranks: Dominant distribution network combined with deep portfolio integration across genomic workflows.Regional Dominance: Worldwide presence with major market share in North America and Europe.Product Line: QuantStudio 3D Digital PCR System, Absolute Q dPCR System, Master Mixes.
4. Roche Diagnostics
   Healthcare giant integrating advanced digital PCR systems into centralized diagnostic oncology workflows.Founded: 1896 | HQ: Basel, Switzerland.Why It Ranks: Massive enterprise reach and proprietary digital technology tailored for clinical oncology.Regional Dominance: Strong leadership across European healthcare systems and North American medical centers.Product Line: Digital LightCycler System, High-Precision Digital Assays, Specialty Reagents.
5. Stilla Technologies
   Innovative biotech specializing in high-multiplex crystal digital PCR via microfluidic micro-drop partitioning.Founded: 2013 | HQ: Villejuif, France.Why It Ranks: Recognized pioneer of multicolor Crystal Digital PCR technology enabling high-plex target analysis.Regional Dominance: Strong presence in European research hubs with expanding North American sales channels.Product Line: Naica System, Ruby Chips, Opal Chips, Crystal Miner Analysis Software.
6. Agilent Technologies
   Precision lab instruments leader providing quantitative microfluidic solutions for genomic assay development.Founded: 1999 | HQ: Santa Clara, California, USA.Why It Ranks: Trusted brand reputation and broad integration within pharmaceutical research and quality control.Regional Dominance: Widespread market coverage across North America, Europe, and key Asian markets.Product Line: Bioanalyzer Systems, Genomic Reagents, Custom Target Enrichment Kits.
7. Standard BioTools (formerly Fluidigm)
   Microfluidics pioneer supplying high-throughput integrated fluidic circuits for precise nucleic acid target profiling.Founded: 1999 | HQ: South San Francisco, California, USA.Why It Ranks: Industry-standard microfluidic technology enabling massive simultaneous target partitioning and analysis.Regional Dominance: Established market presence in North America, Japan, and Western European research centers.Product Line: Biomark HD System, X9 High-Throughput System, Microfluidic Integrated Fluidic Circuits.
8. JN Medsys
   Specialized molecular diagnostic developer focused on cost-effective, user-friendly digital PCR platform solutions.Founded: 2010 | HQ: Singapore.Why It Ranks: Cost-efficient tube-based digital PCR system design lowering barriers for mid-sized laboratories.Regional Dominance: Dominant footprint in Southeast Asia with expanding distribution across Europe and Latin America.Product Line: Clarity Digital PCR System, Clarity High-Throughput Reader, Consumables.
9. Formulatrix
   Automation solutions engineer introducing matrix-based microfluidic digital PCR instrumentation for life science laboratories.Founded: 2002 | HQ: Bedford, Massachusetts, USA.Why It Ranks: High innovation capability in automated liquid handling and low-volume sample microfluidic partitioning.Regional Dominance: Strong presence in North American biopharma hubs and Western European research institutes.Product Line: Constellation Digital PCR System, Automated Microfluidic Reagents, Plate Readers.
10. Sysmex Corporation
    Clinical diagnostic innovator deploying digital PCR solutions into routine liquid biopsy diagnostic applications.Founded: 1968 | HQ: Kobe, Japan.Why It Ranks: Direct clinical integration of dPCR technology into oncology diagnostics and disease monitoring.Regional Dominance: Unmatched market control in Japan and Asia-Pacific, backed by strong European distribution.Product Line: Plasma-Seq dPCR Systems, OncoBEAM Digital PCR Assays, Diagnostic Reagents.

Schedule a meeting with our market experts to discuss the exclusive Digital PCR Market report and find the right research solution for your business.

Conclusion

The Digital PCR market is transitioning from niche research to frontline clinical diagnostics, driven by non-invasive liquid biopsy and absolute pathogen tracking. Advanced automation, multiplexing microfluidics, and simplified benchtop workflows lower entry barriers, enabling widespread lab adoption. As regulatory frameworks align and reimbursement expands globally, digital PCR will remain essential for precision medicine, early cancer detection, and standardized disease monitoring.